Efficacy and Bone Safety of Sotagliflozin 400 and 200 mg Versus Placebo in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control
Clinical trial NCT03386344 · TERMINATED
Trial details
- NCT number
- NCT03386344
- Sponsor
- Lexicon Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-19
- Primary completion
- 2019-05-22
- Enrollment
- 376
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.